SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Mar-24 6:48 PM View: | Cidara Therapeutics, Inc. (CDTX) | 15-Mar-24 | Grant | 108,750 | -- | -- | 48% 227.21K to 335.96K | |
12-Mar-24 9:45 PM View: | Cidara Therapeutics, Inc. (CDTX) | 11-Mar-24 | Sale | 18,931 | $0.67 | $12,680.00 | (8%) 246.14K to 227.21K | |
29-Mar-23 5:24 PM View: | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Grant | 90,000 | -- | -- | 61% 148.14K to 238.14K | |
13-Mar-23 9:20 PM View: | Cidara Therapeutics, Inc. (CDTX) | 13-Mar-23 | Private Sale | 6,648 | $1.53 | $10,171.40 | (4%) 154.79K to 148.14K | |
19-Sep-22 8:28 PM View: | Cidara Therapeutics, Inc. (CDTX) | 19-Sep-22 | Option Sale | 15,642 | $0.77 | $12,035.00 | (9%) 166.43K to 150.79K | |
19-Sep-22 8:28 PM View: | Cidara Therapeutics, Inc. (CDTX) | 15-Sep-22 | Option Exercise | 50,000 | -- | -- | 43% 116.43K to 166.43K | |
04-Apr-22 5:21 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 117,251 | -- | -- | 586% 20.0K to 137.25K | |
04-Apr-22 5:21 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Payment of Exercise | 24,820 | $0.83 | $20,600.60 | (18%) 137.25K to 112.43K | |
15-Nov-21 6:38 PM View: | Cidara Therapeutics, Inc. (CDTX) | 12-Nov-21 | Market Purchase | 20,000 | $1.54 | $30,800.00 | 100% 0 to 20.0K | 5% |
31-Dec-20 9:20 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 30-Dec-20 | Payment of Exercise | 25,000 | $4.64 | $116,000.00 | (68%) 36.6K to 11.6K | < 1% |
27-Dec-19 7:01 AM View: | Brainstorm Cell Therapeutic... (BCLI) | 24-Dec-19 | Market Purchase | 11,600 | $3.96 | $45,929.00 | 46% 25.0K to 36.6K | (7%) |
09-Sep-19 8:00 AM View: | Brainstorm Cell Therapeutic... (BCLI) | 06-Sep-19 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K |